1997
DOI: 10.1002/1529-0131(199707)40:7<1189::aid-art2>3.0.co;2-4
|View full text |Cite
|
Sign up to set email alerts
|

Vasculitis in the central nervous system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
34
0
1

Year Published

1998
1998
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 245 publications
(35 citation statements)
references
References 63 publications
0
34
0
1
Order By: Relevance
“…Over time, it became apparent to workers in the field that PACNS was a heterogeneous entity, with different subsets based on clinical, laboratory, angiographic and pathological findings 2. Granulomatous angiitis of the CNS (GACNS) is considered the most severe subset of PACNS; it accounts for approximately 20% of all patients with PACNS 3 4. GACNS has also been described in association with cerebral amyloid angiopathy (CAA),57 referred to as amyloid-β related angiitis (ABRA) or CAA-related inflammation.…”
mentioning
confidence: 99%
“…Over time, it became apparent to workers in the field that PACNS was a heterogeneous entity, with different subsets based on clinical, laboratory, angiographic and pathological findings 2. Granulomatous angiitis of the CNS (GACNS) is considered the most severe subset of PACNS; it accounts for approximately 20% of all patients with PACNS 3 4. GACNS has also been described in association with cerebral amyloid angiopathy (CAA),57 referred to as amyloid-β related angiitis (ABRA) or CAA-related inflammation.…”
mentioning
confidence: 99%
“…In a series of 116 patients with pathologically confirmed disease, nearly 70% of patients presented with diffuse neurological dysfunction which included: Decreased cognition (83%) Headache (56%) Seizure (30%) Stroke (14%) Cerebral haemorrhage (12%)4 …”
Section: Discussionmentioning
confidence: 99%
“…Corticosteroids associated with intravenous cyclophosphamide is the usual recommended therapeutic regimen 2 4. Such treatment may lead to iatrogenic complications such as infections and neoplasia because of the alkylating properties of cyclophosphamide 8.…”
Section: Discussionmentioning
confidence: 99%
“…Treatment guidelines are based on empirical data and usually combine glucocorticosteroids and cyclophosphamide. Recommended doses, route and duration are highly variable 3 4. We report the case of a patient with PACNS, characterised by unusually prominent involvement of the posterior cerebral fossa and successful treatment with mycophenolate mofetil (MMF) in combination with steroids.…”
mentioning
confidence: 99%